Clinical Liver Disease
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 111:15:50
- Mais informações
Informações:
Sinopse
Clinical Liver Disease (CLD), an official digital learning resource of The American Association for the Study of Liver Diseases is an interactive, up-to-date source of education, designed for physicians and healthcare providers caring for the patient with liver disease. CLD provides current and clinically relevant information through educational interventions every two months.
Episódios
-
![15-4: Isolated Elevated Bilirubin]()
15-4: Isolated Elevated Bilirubin
24/10/2020 Duração: 09minInterview with Hersh Shroff and Haripriya Maddur
-
![15-4: Nutrition Management Strategies for Nonalcoholic Fatty Liver Disease: Treatment and Prevention]()
15-4: Nutrition Management Strategies for Nonalcoholic Fatty Liver Disease: Treatment and Prevention
24/10/2020 Duração: 09minInterview with Evelyn F. Miller
-
![15-4: Spotlight on Impactful Research: Long-Term Calcineurin Inhibitor Therapy and Brain Function in Patients After Liver Transplantation]()
15-4: Spotlight on Impactful Research: Long-Term Calcineurin Inhibitor Therapy and Brain Function in Patients After Liver Transplantation
24/10/2020 Duração: 09minInterview with Amanda Cheung
-
![15-4: EASL Clinical Practice Guidelines on the Management of Benign Liver Tumors]()
15-4: EASL Clinical Practice Guidelines on the Management of Benign Liver Tumors
24/10/2020 Duração: 09minInterview with Massimo Colombo
-
![15-4: Reactivation of Hepatitis B Virus: A Review of Clinical Guidelines]()
15-4: Reactivation of Hepatitis B Virus: A Review of Clinical Guidelines
24/10/2020 Duração: 09minAudible Article by Anthony Myint, Myron J. Tong, and Simon W. Beaven
-
![15-4: Isolated Elevated Bilirubin]()
15-4: Isolated Elevated Bilirubin
24/10/2020 Duração: 09minAudible Article by Hersh Shroff and Haripriya Maddur
-
![15-4: Applications and Limitations of Noninvasive Methods for Evaluating Hepatic Fibrosis in Patients with Nonalcoholic Fatty Liver Disease]()
15-4: Applications and Limitations of Noninvasive Methods for Evaluating Hepatic Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
24/10/2020 Duração: 09minAudible Article by Ann Robinson and Robert J. Wong
-
![15-4: A Big Step Forward in Hepatitis C Screening]()
15-4: A Big Step Forward in Hepatitis C Screening
24/10/2020 Duração: 09minAudible Article by Nikhil Kapila and Andrew J. Muir
-
![15-4: Nutrition Management Strategies for Nonalcoholic Fatty Liver Disease: Treatment and Prevention]()
15-4: Nutrition Management Strategies for Nonalcoholic Fatty Liver Disease: Treatment and Prevention
24/10/2020 Duração: 09minAudible Article by Evelyn F. Miller
-
![15-4: Spotlight on Impactful Research: Long-Term Calcineurin Inhibitor Therapy and Brain Function in Patients After Liver Transplantation]()
15-4: Spotlight on Impactful Research: Long-Term Calcineurin Inhibitor Therapy and Brain Function in Patients After Liver Transplantation
24/10/2020 Duração: 09minAudible Article by Amanda Cheung
-
![15-4: Integrating Palliative Care in the Management of Patients with Advanced Liver Disease]()
15-4: Integrating Palliative Care in the Management of Patients with Advanced Liver Disease
24/10/2020 Duração: 09minAudible Article by Arpan Patel and Nneka N. Ufere
-
![15-4: EASL Clinical Practice Guidelines on the Management of Benign Liver Tumors]()
15-4: EASL Clinical Practice Guidelines on the Management of Benign Liver Tumors
24/10/2020 Duração: 09minAudible Article by Massimo Colombo
-
![15-5: Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic]()
15-5: Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic
24/10/2020 Duração: 09minAudible Article by George Lau and John W. Ward
-
![15-5: COVID-19: Management of Decompensated Cirrhosis and Liver Transplant Recipients]()
15-5: COVID-19: Management of Decompensated Cirrhosis and Liver Transplant Recipients
24/10/2020 Duração: 09minAudible Article by Russell Rosenblatt and Elizabeth C. Verna
-
![15-5: Chronic Liver Disease and COVID-19: Alcohol Use Disorder/Alcohol-Associated Liver Disease, Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Autoimmune Liver Disease, and Compensated Cirrhosis]()
15-5: Chronic Liver Disease and COVID-19: Alcohol Use Disorder/Alcohol-Associated Liver Disease, Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Autoimmune Liver Disease, and Compensated Cirrhosis
24/10/2020 Duração: 09minAudible Article by Tatyana Kushner and John Cafardi
-
![15-5: SARS-CoV-2 and the Liver: Considerations in Hepatitis B and Hepatitis C Infections]()
15-5: SARS-CoV-2 and the Liver: Considerations in Hepatitis B and Hepatitis C Infections
24/10/2020 Duração: 09minAudible Article by K. Rajender Reddy
-
![15-5: Telemedicine and Telehepatology During the COVID-19 Pandemic]()
15-5: Telemedicine and Telehepatology During the COVID-19 Pandemic
24/10/2020 Duração: 09minAudible Article by Oren K. Fix and Marina Serper
-
![15-5: Potential Treatments for SARS-CoV-2 Infection]()
15-5: Potential Treatments for SARS-CoV-2 Infection
24/10/2020 Duração: 09minAudible Article by Sameer K. Berry and Robert J. Fontana
-
![15-5: Interrelationship Between Coronavirus Infection and Liver Disease]()
15-5: Interrelationship Between Coronavirus Infection and Liver Disease
24/10/2020 Duração: 09minAudible Article by Esperance A.K. Schaefer, Aswini Arvind, Patricia P. Bloom, and Raymond T. Chung
-
![15-5: The COVID-19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief]()
15-5: The COVID-19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief
24/10/2020 Duração: 09minAudible Article by John W. Ward and Carlos del Rio
